GlassScriptPhysician profile
Justina Jacob
NPI 1972165058
$1,209.65
in general payments reported to CMS, 2019-2025
13 companies · $37.75 in 2025
The $37.75 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $121 · 2021: $38.01 · 2022: $287 · 2023: $514 · 2024: $211 · 2025: $37.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $222.85 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $166.36 | 2022-2025 | Miebo |
| Alcon Vision LLC | $147.05 | 2023 | Hydrus Microstent |
| Abbvie INC. | $134.86 | 2022-2023 | |
| Allergan, INC. | $124.53 | 2022 | |
| Sight Sciences, INC. | $92.91 | 2024 | Omni Surgical System |
| Eyevance Pharmaceuticals LLC | $90.91 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $68.04 | 2020-2021 | |
| Genzyme Corporation | $50.00 | 2024 | |
| Oyster Point Pharma, INC. | $48.21 | 2023-2024 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $29.34 | 2024 | Oxervate |
| Harrow Eye, LLC | $17.55 | 2025 | Vevye |
| Amgen INC. | $17.04 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justina Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.